Sonohaler ApS

Startup

At Sonohaler, we build acoustic and AI-based digital inhalers and solutions that transform mechanical inhalers into smart products, enabling enhanced management of acute and chronic respiratory conditions.

Our currently in-development product Sono Two will be the first capsule base dry powder inhaler with built-in digital capabilities to digitalise compliance data and evaluate inhalation performance. The next-generation inhaler is being designed to deliver a broad range of treatments including localised vaccine delivery for conditions such as Covid, Influenza, and TB. 

For more information, please refer to our website: www.sonohaler.com